Marshall Wace’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2M | Buy |
1,209,484
+321,947
| +36% | +$10.2M | 0.04% | 332 |
|
|
2025
Q1 | $29.5M | Sell |
887,537
-42,207
| -5% | -$1.4M | 0.04% | 380 |
|
|
2024
Q4 | $32M | Buy |
929,744
+579,103
| +165% | +$19.9M | 0.04% | 375 |
|
|
2024
Q3 | $14M | Buy |
350,641
+45,029
| +15% | +$1.8M | 0.02% | 578 |
|
|
2024
Q2 | $9.22M | Buy |
305,612
+181,092
| +145% | +$5.46M | 0.01% | 698 |
|
|
2024
Q1 | $4.18M | Buy |
+124,520
| New | +$4.18M | 0.01% | 937 |
|
|
2023
Q1 | – | Sell |
-162,906
| Closed | -$8.98M | – | 2334 |
|
|
2022
Q4 | $8.98M | Buy |
162,906
+141,571
| +664% | +$7.8M | 0.02% | 753 |
|
|
2022
Q3 | $944K | Buy |
+21,335
| New | +$944K | ﹤0.01% | 1821 |
|
|
2022
Q2 | – | Sell |
-83,961
| Closed | -$4.09M | – | 2899 |
|
|
2022
Q1 | $4.09M | Buy |
83,961
+34,974
| +71% | +$1.7M | 0.01% | 1321 |
|
|
2021
Q4 | $2.09M | Buy |
48,987
+34,098
| +229% | +$1.45M | ﹤0.01% | 1599 |
|
|
2021
Q3 | $570K | Buy |
+14,889
| New | +$570K | ﹤0.01% | 1798 |
|
|
2021
Q2 | – | Sell |
-15,545
| Closed | -$514K | – | 2275 |
|
|
2021
Q1 | $514K | Buy |
+15,545
| New | +$514K | ﹤0.01% | 1634 |
|